Unicycive Share Price
NASDAQ: UNCY | Micro Cap | HealthcareUnicycive Stock Performance
Unicycive Share Price Today
As of 21 November 2026, Unicycive Therapeutics, Inc.'s share price is $3.35. The stock opened at $3.48, compared to its previous close of $3.54. During today's trading session, Unicycive Therapeutics, Inc.'s share price traded between $3.35 and $3.62, with an average price of $3.48. Over the past 52 weeks, the stock has recorded a high of $8.74 and a low of $3.33. In terms of performance, Unicycive Therapeutics, Inc.'s share price has declined by 54.48% over the last six months and is down 48.14% on a year-on-year basis.
Unicycive Share Price Chart
Unicycive Quarterly Profit & Loss
All figures in USD
Unicycive Annual Profit & Loss
All figures in USD
Unicycive Balance Sheet
All figures in USD Million
Unicycive Cash Flow
All figures in USD Million
Corporate Actions
About Unicycive
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
Unicycive Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $3.60 | $3.35 | -10.55% |
Oct 2026 | $4.71 | $3.75 | -20.32% |
Sep 2026 | $5.17 | $4.70 | -14.39% |
Aug 2026 | $5.00 | $5.49 | +9.47% |
Jul 2026 | $4.58 | $5.01 | +6.03% |
Jun 2026 | $7.50 | $4.73 | -35.73% |
May 2026 | $7.72 | $7.36 | -3.92% |
Apr 2026 | $6.78 | $7.66 | +16.50% |
Mar 2026 | $6.70 | $6.58 | -5.26% |
Feb 2026 | $6.00 | $6.94 | +16.54% |
Jan 2026 | $5.79 | $5.96 | +3.21% |
Dec 2025 | $6.42 | $5.77 | -10.68% |